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Myf5, one of the basic helix– loop–helix transcription factors, controls muscle differentiation and is expressed in somites during early
embryogenesis. However, the transcription factors bound to the cis-elements of myf5 are poorly understood. In this study, we used the yeast one-
hybrid assay and found that Forkhead box d3 (Foxd3) interacted specifically with the 82/62 cassette, a key element directing somite-specific
expression of myf5. The dual-luciferase assay revealed that the expression of Foxd3 potently transactivated the myf5 promoter. Knocking down
foxd3 with morpholino oligonucleotide (MO) resulted in a dramatic down-regulation of myf5 in somites and adaxial cells but not in the presomitic
mesoderm. On the other hand, myod expression remained unchanged in foxd3 morphants. Foxd3 mediation of myf5 expression is stage-
dependent, maintaining myf5 expression in the somites and adaxial cells during the 7- to 18-somite stage. Furthermore, in the pax3 morphant, the
expression of foxd3 was down-regulated greatly and the expression of myf5 was similar to that of the foxd3 morphant. Co-injection of foxd3
mRNA and pax3-MO1 greatly restored the expression of myf5 in the somites and adaxial cells, suggesting that pax3 induces foxd3 expression,
which then induces the expression of myf5. This report is the first study to show that Foxd3, a well-known regulator in neural crest development, is
also involved in myf5 regulation.
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In vertebrates, the specification of muscle progenitor cells in
the somites depends on inductive signals emanating from
adjacent tissues, such as the neural tube, the notochord, and the
dorsal and lateral ectoderm. In response to inducers, muscle
precursor cells (myoblasts) start expressing several transcrip-
tional activators that control the expression of muscle structural
genes. A family of muscle regulatory factors (MRFs) with a
basic DNA binding motif and a basic helix– loop–helix
dimerization domain has been identified in mammals, birds,
frogs, fish, insects, and nematodes (Michelson et al., 1990;
Hopwood et al., 1991; Buonanno et al., 1992; Saitoh et al.,
1993; Krause et al., 1994; Chen et al., 2000, 2001). Proteins in
this family include Myod (Davis et al., 1987), Myogenin
(Braun et al., 1989a; Edmondson and Olson, 1989; Wright et
al., 1989), Myf5 (Braun et al., 1989b), and MRF4/herculin/0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Taipei, Taiwan.Myf6 (Rhodes and Konieczny, 1989; Braun et al., 1990; Miner
and Wold, 1990).
In mice, Myf5 is activated at different anatomical sites in the
embryo under the control of distinct, cis-acting regulatory
elements (Hadchouel et al., 2000; Summerbell et al., 2000;
Carvajal et al., 2001). An enhancer, 6.6 kb upstream, is
required for myf5 expression in the epaxial domain (Gustafsson
et al., 2002). A 270-bp core enhancer, about 57 kb upstream,
directs myf5 expression in limbs and maintains myf5 expres-
sion in somites (Buchberger et al., 2003). Another enhancer
directs myf5 expression in cervical somites and restricts myf5
transcription in the myotome. In Xenopus, two negative
regulatory elements have been identified in the Xmyf5
promoter, which controls Xmyf5 expression. An interferon
regulatory factor-like DNA binding element down-regulates
Xmyf5 expression in differentiating myocytes (Mei et al.,
2001), and a distal TCF-3 binding site restricts Xmyf5
expression in the midline mesoderm by means of Wnt/h-
catenin signals (Yang et al., 2002). A T-box binding site
mediates dorsal activation of Xmyf5 transcription and is
involved in the regulation of muscle development (Lin et al.,
2003). In zebrafish myf5, the upstream sequence 82 to 190 (2006) 359 – 372
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somites but the 62/1 segment cannot (Chen et al., 2001).
Recently, Chen et al. (2003) demonstrated that the 82/62
regulatory cassette in zebrafish myf5 is a cis-element that is
able to direct somite-specific expression and repress nonspe-
cific expression during early embryogenesis. Although pro-
moter analysis and identification of cis-regulatory elements
have been carried out with mouse, Xenopus, and zebrafish
myf5, the trans-acting factors that actually bind to cis-acting
elements in myf5 remain unknown.
Somite patterning is under the control of a variety of signals
provided by the dorsal neural tube, notochord, floor plate,
surface ectoderm, and lateral plate mesoderm (Mu¨nsterberg et
al., 1995; Marcelle et al., 1997; Pourquie´ et al., 1996; Hirsinger
et al., 1997; Yamaguchi, 1997; Currie and Ingham, 1998;
Tajbakhsh et al., 1998; Reshef et al., 1998). Several transcrip-
tion factors and signaling modulators, such as bone morpho-
genetic protein 4 (BMP4; Cossu et al., 1996), Noggin
(Hirsinger et al., 1997), Wnt (Ikeya and Takada, 1998;
Tajbakhsh et al., 1998; Borycki et al., 1999), Sonic Hedgehog
(Shh; Coutelle et al., 2001), Gli (Gustafsson et al., 2002), and
Pax3 (Marcelle et al., 1995; Maroto et al., 1997; Tajbakhsh et
al., 1997), play important roles in mediating the response of
signals from surrounding tissues to induce expression of
MRFs. The regulatory network of mouse myf5 has been
elucidated (Cossu and Borello, 1999; Buckingham, 2001; Roth
et al., 2003; Tajbakhsh, 2003), and it is proposed that pax3
regulates mouse myf5 expression in an indirect manner
(Maroto et al., 1997; Tajbakhsh et al., 1997; Roth et al.,
2003). However, the detailed molecular interaction among
factors in the regulatory network during the time of commit-
ment to modulate myf5 expression has yet to be revealed.
In this study, using a yeast one-hybrid assay, we determined
that Foxd3 interacted specifically with the 82/62 regulatory
element of zebrafish myf5. Foxd3 also plays an important role
in maintaining myf5 expression in the somites and adaxial
cells. This Foxd3 mediation of myf5 is stage-dependent.
Furthermore, we demonstrate that the expression of foxd3 in
the pax3 morphant was down-regulated greatly and that the
expression of myf5 was similar to that of the foxd3 morphant.
Injection of foxd3 mRNA rescued the defects caused by pax3
morpholino oligonucleotide (MO), suggesting that pax3
induces foxd3 expression, which then induces the expression
of myf5. This article is the first study to demonstrate that Foxd3
mediates myf5 expression and is involved in myogenesis
during zebrafish embryogenesis.Materials and methods
Yeast one-hybrid screening
Yeast one-hybrid screening was performed according to the protocol of the
manufacturer (Clontech). The bait plasmids pHISi-6 (82/62) and pLacZi-
6 (82/62) were constructed using synthetic DNA oligomers containing six
repeats of the myf5 82/62 cassette. Four plasmids were used in the selection
procedure as negative controls. They included p53HIS, which contains the
consensus p53 binding site; pGAD424, which contains only the GAL4
activation domain; and pHISi-m4m5 and pLacZi-m4m5, which contain fourrepeats of the myf5 82/62 cassette in which the 70/62 sequence was
mutated to GAAGTTAAC (m4m5; Chen et al., 2003). The cDNAwas inserted
into a plasmid, pGADT7-Rec, by homologous recombination in yeast.
Transformed plasmids were recovered with a yeast plasmid isolation kit
(Clontech). The plasmids isolated from each clone were transformed into
Escherichia coli DH5a cells for amplification.
Fish embryos
Zebrafish (AB strain) were maintained at 28.5-C under a 14-h light/10-h dark
photoperiod. After fertilization, eggs were collected and cultured in an aquarium.
The number of embryonic cleavages was counted, and somite formation was
observed under a fluorescent stereomicroscope MZ FLIII (Leica).
Knockdown microinjection of zebrafish embryos
MOs were obtained from Gene Tools. The sequences of MOs were
designed as follows: foxd3-MO1, TGCTGCTGGAGCAACCCAAGGTAAG,
antisense nucleotides 160 to 184 of zebrafish foxd3 cDNA (GenBank accession
no. AF052249); foxd3-MO2, CACTGGTGCCTCCAGACAGGGTCAT, anti-
sense nucleotides 197 to 221 of zebrafish foxd3 cDNA; foxd3-MO-sense,
ATGACCCTGTCTGGAGGCACCAGTG, sense nucleotides 197 to 221 of
zebrafish foxd3 cDNA; pax3-MO1, GCTAATGCGGTCATATCTCCTCTGC,
antisense nucleotides 266 to 290 of zebrafish pax3 cDNA (GenBank accession
no. NM131277); pax3-MO2, ACGAAAAAAGGATGCACGAAGCACT, an-
tisense nucleotides 241 to 265 of zebrafish pax3 cDNA; myf5-MO,
TACGTCCATGATTGGTTTGGTGTTG, antisense nucleotides 28 to 52 of
zebrafish myf5 cDNA (GenBank accession no. NM131576). All oligonucleo-
tides were prepared at a stock concentration of 1 mM and diluted to the desired
concentration for microinjection into each embryo.
Electrophoretic mobility shift assay
The 82/62 cassette, the mutated sequence of 82/62 (sequence at
70/62 was mutated to GAAGTTAAC; m4m5) and a nonspecific sequence
(Non-30fr) were used as oligonucleotide probes for the binding assay (Chen et
al., 2003). All probes were labeled with g-[32P]ATP (3,000 ACi/ml) using T4
polynucleotide kinase (NEB). Probes, recombinant Foxd3 protein (50 or 500
ng), and 1 Ag of poly(dIdC) were added to the reaction buffer (10 mM Tris at
pH 7.5, 50 mM NaCl, 0.5 mM ethylenediaminetetraacetic acid pH 8.0, 0.5 mM
dithiothreitol, 5% glycerol) and incubated at 30-C for 30 min. Unlabeled 82/
62 cassette, Non-30fr, and m4m5 were used for competitive inhibition. After
reacting, all products were analyzed by 6% acrylamide gel electrophoresis (79:1
acrylamide:bisacrylamide). After transferring the bands to a 3M filter and
drying the gel, X-ray film was exposed to the sample for 2 days.
Cloning zebrafish Foxd3 cDNA and plasmid constructions
Full-length cDNA coding for zebrafish foxd3 was obtained by polymerase
chain reaction (PCR) from a cDNA library of 14–18 h postfertilization (hpf)
zebrafish embryos using the 5V-primer CTCGAGATGACCCTGTCTGGAGG-
CACC and the 3V-primer CTCGAGTCATTGAGAAGGCCATT in which an
XhoI site was included. The PCR products were first ligated into pGEMT-easy
vector (Promega), then digested by XhoI, and subcloned into a pET-15b vector
(Novagen). The coding region of zebrafish foxd3 was amplified by PCR using
the 5V-primer GGTACCATGACCCTGTCTGGAGGCACC, in which a KpnI
site was included, and the 3V-primer TCATTGAGAAGGCCATTTCGA-
TACCG. The PCR products were subcloned into the pGEMT-easy vector
(Promega), digested by KpnI and NotI, then cloned into the pCMVm vector,
which contains the CMV promoter and enhancer (Chen et al., 2003). Plasmids
pZMYP-2937E and pZMYP-6212E, to which green fluorescent protein was
fused with the upstream 3 and 6 kb of zebrafish myf5, respectively, were
described previously (Chen et al., 2001). Plasmid pRL-ZMYP3.0, containing
an upstream 2.9 kb of zebrafish myf5 that was recovered from an AgeI–PstI-
cut pZMYP-2937E, was subcloned into the NheI –PstI-cut phRL-Null vector
(Promega) in which the NheI was blunted. Plasmid pRL-ZMYP6.0, containing
the upstream 6.2 kb of myf5 that was recovered from an AgeI –PstI-cut
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strategy.
Preparation of recombinant proteins in vitro
E. coli BL21 (DE3)/pLysS containing zebrafish foxd3 cDNA was cultured
to produce recombinant Foxd3. Following induction, E. coli was treated with
0.5 mM isopropyl-1-thio-h-d-galacto-pyranoside for 4 h at 37-C. After the
cells were lysed, recombinant Foxd3 was purified with a Ni-NTA spin column
(Qiagen).
Cell culture
Monkey kidney COS-1 cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM, Biowest) containing 10% fetal bovine serum (Biowest),
which was heat-inactivated by incubating for 30 min at 56-C, supplemented
with 1 penicillin/streptomycin/glutamine (Biowest), and then incubated at
37-C in an atmosphere of 5% CO2 and 95% air. Fresh culture medium was
provided every 2 or 3 days, and the cells were subcultured before reaching 70%
confluency. The embryonal carcinoma cell line P19 was cultured in alpha
minimum essential medium (Gibco), 7.5% bovine calf serum (Biowest), 2.5%
fetal bovine serum, and 1 penicillin/streptomycin/glutamine. Medium was
renewed at least every 48 h and subcultured every 2 or 3 days.
Dual-luciferase assay
About 1  105 cells were seeded onto each well of six-well plates 24 h prior
to transfection. Cells were transfected by the lipofectamine method (Invitrogen)
according to the manufacturer’s instruction. Transfection mixtures normally
contained 6 Al of lipofectamine and 1 to 2 Ag of plasmid constructs of firefly
luciferase and Renilla luciferase (RL). After a 48-h transfection, cells were
harvested for luciferase assay by using the Dual-Luciferase Reporter Assay
System (Promega). Luciferase activity was measured from three separated
experiments in a Luminoskan Ascent (Thermo Labsystems).
RNA in situ hybridization
Whole-mount in situ hybridization of whole embryos was performed by
using digoxigenin (DIG) -labeled riboprobes of myf5, foxd3, myod, myogenin,
and a-actin. We followed the procedures as described by Chen et al. (2001),
except that phosphate-buffered saline with 0.1% Tween 20, 2 mg/ml bovine
serum albumin, 5% sheep serum, and 1% dimethyl sulfoxide were used in the
blocking solution. To determine the co-localization of myf5 and foxd3
transcripts, double in situ hybridizations were performed following the scheme
of Jowett (2001), except that foxd3 was labeled with fluorescein-UTP (Roche)
and myf5 was labeled with DIG-UTP (Roche).
mRNA injection for the rescue experiment
Capped mRNAs of foxd3, myf5, and red fluorescent protein (RFP) were
synthesized according to the protocol of the manufacturer (Epicentre). The
resulting mRNAwas diluted to 11 or 22 ng/Al for foxd3 mRNA, 130 or 260 ng/
Al for myf5 mRNA, and 44 ng/Al for RFP mRNA with distilled water, and 2.3
nl of each was injected into 1-cell stage embryos. In the rescue experiments,
embryos were observed at 13- to 16-somite stage in terms of morphological
defects and the expression patterns of target genes by using whole mount in situ
hybridization.
Results
Foxd3 is the cognate protein bound to the myf5 82/62
cassette
Yeast one-hybrid screening was used to identify the factor
bound to the 82/62 cassette of zebrafish myf5. Six copies ofthe 82/62 cassette were inserted in the region upstream of
the Saccharomyces cerevisiae selection marker YM4271. A
cDNA library constructed from mRNA of 15–18 hpf embryos
was screened, and 8.5  103 clones were grown on minimal
medium. About 162 colonies that not only were able to grow
on the selective medium but that also were lacZ-positive were
isolated. Then, their insert DNA fragments were cloned and
sequenced. After these cDNA sequences were identified from
the gene bank using the BLAST procedure, we selected 83
putative colonies containing the full-length cDNA and back-
transformed them into yeasts. Finally, there were 17 colonies
containing cDNA fragments that were able to interact
specifically with the 82/62 bait. One of these colonies
containing foxd3 cDNA was chosen for further study because
this cDNA insert was somite-positive after in situ hybridiza-
tion. The binding specificity of Foxd3 and 82/62 cassette
was evaluated with two assays. First, recombinant yeasts,
containing Foxd3 fused to the activation domain Gal4, grew in
the selective medium only when they contained the wild-type
myf5 82/62 cassette. Recombinant yeasts harboring the
mutated sequence within 82/62 did not grow (Fig. 1A).
Second, h-galactosidase activity was detected in yeasts
containing Foxd3 fused with the activation domain when the
myf5 82/62 cassette was upstream of lacZ. However, h-
galactosidase activity was not detectable in yeasts containing
mutated sequences of the myf5 82/62 cassette (Fig. 1B).
Electrophoretic mobility shift assay demonstrates that
recombinant Foxd3 binds to the 82/62 cassette
Electrophoretic mobility shift assay (EMSA) was used to
determine whether the myf5 82/62 cassette is able to bind
Foxd3 in vitro. Recombinant Foxd3 produced by E. coli
interacted specifically with the 82/62 probe, producing the
shifted band shown on the gel (Fig. 2). In addition, the shifted
band of DNA–protein complex was lost completely when
excess amounts of cold 82/62 oligonucleotides were added.
But, neither the nonspecific DNA competitor (Non30fr; Fig. 2,
lane 7) nor the mutated 82/62 competitor (m4m5; Fig. 2,
lane 6) interfered by forming a specific complex between
recombinant Foxd3 and the 82/62 probe. Thus, the
interaction between Foxd3 and the myf5 82/62 cassette is
specific.
Transactivation of the myf5 promoter by Foxd3
To test the functional consequences of Foxd3 interactions
with the myf5 82/62 cassette, we performed transient
transfection assays with a luciferase reporter gene under the
control of the zebrafish myf5 promoter in the COS-1 and P19
cell lines. The upstream 3-kb or 6-kb region of zebrafish myf5
was cloned to the phRL-Null vector. Results showed that the
luciferase activity in COS-1 cells in the presence of
recombinant Foxd3 was 2.4-fold (pRL-ZMYP3.0) or 2.6-fold
(pRL-ZMYP6.0) greater than that of the untreated group after
48-hr transfection (n = 4, P < 0.05; Fig. 3). This case was
also the finding when we used the P19 cells: the luciferase
Fig. 1. The yeast one-hybrid system was used to identify Foxd3 bound to the myf5 82/62 cassette. (A) The yeast one-hybrid assay of clones transfected with the
plasmids indicated the following: pHISi-6 (82/62), which contains six repeats of 82/62; pGADT7-zfoxd3, which contains foxd3 with the GAL4 activation
domain; pHISi-m4m5, which contains the mutated 82/62 cassette; p53HIS/pGAD53m, the positive control; p53HIS/pGAD424, the negative control. Yeasts that
harbored plasmids containing wild-type 82/62 grew under growth-inhibiting conditions (histidine and leucine were absent, 60 mM of 3-amino-1,2,4-triazole was
present) when Foxd3 fused to the activation domain was expressed. Yeasts containing plasmids with mutated 82/62 did not grow. (B) The colony-lift filter
method was used to perform h-galactosidase assays. Yeasts were transformed, as indicated, with each of the following plasmids: pLacZi-6 (82/62), the bait
plasmid that contains six repeats of 82/62 and carries the lacZ reporter gene; pLacZi-m4m5, which contains four repeats of the mutated 82/62 sequence;
p53BLUE/pGAD53m, the positive control; p53BLUE/pGAD424, the negative control. Positive h-galactosidase activity, shown in blue, was detected only when the
foxd3 activation domain fusion was expressed in yeasts containing wild-type 82/62. No activity was detected in yeasts with mutated 82/62.
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(pRL-ZMYP6.0) by the presence of Foxd3 (n = 4, P < 0.05;
Fig. 3). Thus, we conclude that the interaction between Foxd3
and the myf5 promoter resulted in transactivation of gene
expression.
Expression patterns of myf5 and foxd3 were colocalized
The pattern of foxd3 expression in zebrafish embryos varied
with developmental stage. During the 4- to 6-somite stage,
foxd3 was transcribed in the floor plate, presumptive neural
crest cells, and tail bud (Fig. 4A). During the 7- to 9-somite
stage, foxd3 expression was first detected in the somites (Fig.
4B, arrowhead) and the signals also appeared in the posterior
premigratory crests and tail bud. During the 11- to 16-somite
stage, foxd3 was expressed strongly in the somites and the
signals in the neural crest cells were down-regulated prior to
neural crest migration (Figs. 4C, D). However, faint signals in
the lateral head and in the loose cluster of foxd3-positive cells
in the posterior head increased incrementally with the
formation of each pair of somites (Figs. 4C, D, arrow). In
embryos with 16–28 somites, foxd3 expression in the somites
was high but was down-regulated rapidly in the somites after
the 28-somite stage (data not shown). Use of double in situ
hybridization to detect both the myf5 and the foxd3 transcripts
at the 11- to 13-somite stage revealed that the expression
domains of myf5 and foxd3 coincided greatly in somites and
adaxial cells (Figs. 4E, F), indicating that the expression
patterns of foxd3 and myf5 were colocalized.
In the foxd3 morphant, morphological defects were
dose-dependent
To determine whether Foxd3 affects myf5 expression in
vivo, we used two different MOs: one complementary to 25 bpof the 5V-untranslated region of foxd3 mRNA (foxd3-MO1) and
the other complementary to 25 bp after AUG of foxd3 mRNA
(foxd3-MO2). Embryos that received two types of foxd3-MOs
displayed similar defective phenotypes, whereas embryos that
received only the control MO (foxd3-MO-sense) developed
normally, even when we injected it at a concentration as high as
8 ng/embryo (Table 1). When 4–10 ng of foxd3-MOs were
injected, morphants with 12–14 somites displayed defects in
the head and the tail bud (Figs. 5A, B). Although the frequency
of segmentation defects did not differ in wild-type and foxd3-
MO1-injected embryos, the somites of foxd3 morphants
became broader than the somites of wild-type embryos (Figs.
5C, D). Most abnormalities were mild and included a raised
tail, a reduced head, and wider somites with an irregular
boundary. Minor abnormalities led to serious defects that
retarded development. It is interesting to note that the defects
caused by injecting two foxd3-MOs were dose-dependent and
synergistic (Table 1). To confirm whether the foxd3-MO-
induced defects were specific, we co-injected synthetic foxd3
mRNA and foxd3-MO1. The foxd3-MO1 was used because it
was complementary to a sequence of the 5V-untranslated region,
i.e., it blocked the endogenous foxd3 mRNA but not the
microinjected foxd3 mRNA. Synthetic foxd3 mRNA (25–50
pg) largely rescued the morphological defects induced by
foxd3-MO1 (Table 1), suggesting that the foxd3-MO-induced
defects were specific.
Effects of foxd3 on myf5 expression are stage-dependent
To determine whether the states of differentiation of the
somites were affected in foxd3 morphants, we assayed the
expression of a number of genes that are normally expressed
in somites and other tissues. myf5 expression domains in the
presomitic mesoderm (PSM) of foxd3 morphants and wild-
type embryos were the same, but no signals were detected in
Fig. 2. Binding between purified recombinant Foxd3 and 32P-radiolabeled
oligonucleotide probes was studied with the electrophoretic mobility shift
assay. The arrow indicates the shifted band formed by double-stranded
oligonucleotide and recombinant Foxd3. Three probes were used: cassette
82/62, mutated 82/62 (m4m5, in which the 70/62 sequence was
mutated), and a nonspecific DNA sequence (Non-30fr). Radiolabeled cassette
82/62, without added nuclear extracts, was the negative control (lane 1).
The shifted bands were abolished completely when excess amount of unlabeled
82/62 oligonucleotide was added (lanes 4 and 5). Recombinant Foxd3 did
not bind to m4m5 (lane 8) or Non30fr (lane 9). In addition, m4m5 and Non30fr
competitors did not compete for binding with Foxd3 and cassette 82/62
(lanes 6 and 7).
Fig. 3. Transactivation of the myf5 promoter by Foxd3. Cultured cell lines
COS-1 and P19 were used to study whether Foxd3 transactivates the expression
of zebrafish myf5. In the dual-luciferase assay, luciferase activity was
represented as the fold increase compared to the absence of recombinant
Foxd3. In COS-1 cells, the luciferase activity increased 2.4-fold (pRL-
ZMYP3.0) or 2.6-fold (pRL-ZMYP6.0) when the recombinant Foxd3 was
present. In the P19 cell line, the luciferase activity increased 3.65-fold (pRL-
ZMYP3.0) or 4.16-fold (pRL-ZMYP6.0) when Foxd3 was present. All
transfections and luciferase assays were performed independently at least three
times. Data are means T S.D. Asterisks indicate a mean is significantly different
( P < 0.05).
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stage (Figs. 6A, G). During the 11- to 13-somite stage, myf5
gene expression in morphants was inactivated in the somites
and adaxial cells (located on the lateral portions of somites
1–9) but signals in the PSM were not lost (Figs. 6B, H).
Meanwhile, myf5 expression decreased greatly in the somites
and the adaxial cells during the 14- to 16-somite stage, but
myf5 transcripts were expressed normally in the PSM (Figs.
6C, I). In foxd3 morphants, myf5 was expressed normally in
the PSM: these embryos did not lose myf5 expression
patterns in somites 0 and 1 (Figs. 6G–J, arrowheads).
However, the myf5 signals greatly decreased in the newly
formed somites and in the completely formed somites,
indicating that foxd3 functions to maintain myf5 gene
expression in the somites but not in the PSM during
somitogenesis.
After the 17- to 19-somite stage, endogenous myf5
expression was down-regulated and differences in myf5
expression between wild-type embryos and foxd3 morphants
became negligible (Figs. 6D, J). This down-regulated expres-
sion pattern persisted for wild-type embryos and foxd3
morphants after the 20- to 24-somite stage (Figs. 6E, F vs.Figs. 6K, L). However, at these stages, the expression level of
foxd3 in the somites was still strong. This evidence clearly
demonstrated that the regulation of myf5 through foxd3 was
stage-dependent. Moreover, we also found an unexpected
ectopic expression of myf5 in the tail bud in foxd3 morphants
with raised tails (Fig. 6H, arrow), suggesting that Foxd3 may
play other roles in the tail bud.
Foxd3 modulates expression of myf5 but not myod
We compared the expression of two genes involved in
somitogenesis in foxd3 morphants and wild-type embryos. In
foxd3 morphants, both myogenin (which is downstream of
myf5) and a-actin (the structural protein in somites) clearly
were down-regulated in the somites but were expressed
normally in adaxial cells (Figs. 7C, D, G, H). However, myod
expression in the somites and adaxial cells remained un-
changed (Figs. 7B, F). Furthermore, we noticed that 10 somites
were positive for myod staining in wild-type embryos, whereas
6 were positive in the foxd3-MO1-injected embryos. This
difference may be due to development delay in MO-treated
embryos. Thus, we suggest that Foxd3 specifically regulated
the expression of myf5 but not myod.
foxd3 knockdown morphant can be rescued by injecting myf5
mRNA
To determine whether the foxd3 morphant phenotype could
be rescued by myf5, we co-injected foxd3-MO1 and synthetic
myf5 mRNA. A series of different concentrations of myf5
mRNA was injected together with 8 ng of foxd3-MO1 into
Fig. 4. Temporal and spatial expression of foxd3 in zebrafish embryos at different somite stages. (A) At the 4- to 6-somite stage, foxd3 was transcribed in the floor
plate, presumptive neural crest cells, and tail bud. (B) At the 7- to 9-somite stage, foxd3 transcripts were first detected in the somites (arrowhead) and the signals were
weak in migrating neural crest cells. In addition to the somitic mesoderm, foxd3 mRNA also was found in the tail bud and posterior premigratory crest. (C, D) At the
11- to 16-somite stage, foxd3 transcription increased incrementally after each pair of somites was formed. foxd3 transcripts in the lateral head were down-regulated,
but foxd3 expression was strong in the somites and cranial ganglia posterior to the otic vesicle (arrow). (E, F) In the 11- to 13-somite stage of wild-type embryos,
double in situ hybridization using red-labeled myf5 and blue-labeled foxd3 probes was used to show that expressions of these genes were colocalized in the posterior
part of the somites. Scale bars: 100 Am.
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partially by injecting myf5 mRNA compared to the expression
in embryos that were injected with foxd3-MO1 alone (Table 2;
Fig. 7G vs. J; Fig. 7H vs. K). Co-injection of myf5 mRNA
effectively rescued the expression of myogenin (from 7% to
51% of defects) and a-actin (from 32% to 53% of defects) at
the concentration range of 300–600 pg (Table 2). Moreover,
embryos that were injected with myf5-MO showed reduced
expression of myogenin but not of myod (Fig. 7I). The
expression pattern of myogenin in foxd3 morphants and in
myf5 morphants was similar. Taken together, our data suggest
that myf5 mRNA effectively rescues the foxd3 morphant
phenotype and that the foxd3-MO1 used in this study
specifically inhibits myf5 expression.
Molecular control of pax3, foxd3, and myf5
To define further the molecular network among pax3, foxd3,
and myf5 during zebrafish myogenesis, we injected pax3-MOs
into embryos to repress pax3 expression. Like the strategy of
using foxd3-MOs, two pax3-MOs were designed: pax3-MO1
and pax3-MO2. Embryos that received pax3-MO1 displayed
severe convergence/extension phenotypes. The defects caused
by these two MOs were similar, dose-dependent, and syner-
gistic (Table 1). We found that foxd3 expression was down-
regulated significantly (Fig. 8D vs. E). Meanwhile, myf5expression was restricted in the PSM and weak in somites 0
and 1 and in the adaxial cells on the sides of somites 0 and
1 (Figs. 8A, B). The patterns of myf5 expression were similar
in morphants derived from embryos treated with foxd3-MO1
and pax3-MO-1 (Figs. 7E, 8B). However, in pax3 morphants,
myod clearly was down-regulated in the somites but was
expressed normally in adaxial cells (Figs. 8F, G). Furthermore,
we found that, when 25 pg of foxd3 mRNA and 6 ng of pax3-
MO1 were co-injected, the expression of myf5 was greatly
restored in the somites (Fig. 8C), but it did not rescue myod
expression in the somites (Fig. 8H). Based on these findings,
we conclude that (1) foxd3 specifically regulates expression of
myf5 but not myod, (2) pax3 acts as an upstream regulator of
foxd3, and (3) down-regulation of myf5 in pax3 morphants
occurs because foxd3 is not expressed.
Discussion
The winged helix transcription factor forkhead gene was
first described in Drosophila (Weigel et al., 1989). Rodent
HNF3 transcription factor is very similar (Weigel and Ja¨ckle,
1990; Lai et al., 1990, 1991). Forkhead domains have been
reported in organisms ranging from yeasts to humans (Lai et
al., 1993). Based on conserved residues at distinct positions in
the DNA binding domain, more than 10 different classes of
forkhead genes have been described. Some classes have been
Table 1
Morphological phenotypes of zebrafish embryos derived from fertilized eggs injected with different materials
Injected materials Concentration Number of embryos surviving
among number of injected eggs
Wild-type
phenotype
Number of embryos with abnormal phenotypes
Mild defects Severe defects
foxd3-MO1 4 ng 169/224 (75.4%) 127 (75.1%) 42 (21.6%) 0 (0%)
foxd3-MO1 8 ng 133/155 (85.8%) 56 (42.1%) 65 (48.9%) 12 (9.0%)
foxd3-MO1 10 ng 179/247 (72.5%) 27 (15.1%) 107 (59.8%) 45 (25.1%)
foxd3-MO2 4 ng 132/154 (85.7%) 96 (72.7%) 30 (22.6%) 6 (4.5%)
foxd3-MO2 8 ng 124/159 (78.0%) 12 (9.7%) 92 (74.2%) 20 (16.1%)
foxd3-MO1 + foxd3-MO2 2 + 2 ng 75/89 (84.3%) 22 (29.3%) 40 (53.3%) 13 (17.3%)
foxd3-MO-sense 4 ng 124/127 (97.6%) 124 (100%) 0 (0%) 0 (0%)
foxd3-MO-sense 8 ng 83/84 (98.8%) 83 (100%) 0 (0%) 0 (0%)
myf5-MO 4 ng 72/73 (98.6%) 2 (2.8%) 68 (94.4%) 2 (2.8%)
pax3-MO1 6 ng 92/124 (74.2%) 24 (26.1%) 53 (57.6%) 15 (16.3%)
pax3-MO2 6 ng 77/95 (81.1%) 26 (33.8%) 49 (63.6%) 2 (2.6%)
pax3-MO1 + pax3-MO2 3 ng + 3 ng 81/104 (77.9%) 19 (23.5%) 59 (72.8%) 3 (3.7%)
dsRed mRNA 100 pg 71/79 (89.9%) 71 (100%) 0 (0%) 0 (0%)
foxd3 mRNA + foxd3-MO1 25 pg + 8 ng 136/151 (90.1%) 82 (60.3%) 50 (36.8%) 4 (2.9%)
foxd3 mRNA + foxd3-MO1 50 pg + 8 ng 128/144 (88.9%) 104 (81.3%) 24 (18.7%) 0 (0%)
myf5 mRNA + foxd3-MO1 300 pg + 8 ng 192/257 (74.7%) 70 (36.5%) 108 (56.3%) 14 (7.3%)
myf5 mRNA + foxd3-MO1 600 pg + 8 ng 214/396 (54%) 88 (41.0%) 143 (56.1%) 6 (2.8%)
dsRed mRNA + foxd3-MO1 100 pg + 8 ng 43/54 (79.6%) 17 (39.5%) 23 (53.5%) 3 (7.0%)
foxd3 mRNA + pax3-MO1 25 pg + 6 ng 78/124 (62.9%) 33 (42.3%) 45 (57.7%) 0 (0%)
Fertilized eggs were injected at the 1-cell stage, and then observed at the 13- to 16-somite stage. Embryos with abnormal phenotypes were categorized as having mild
defects, such as raised tail and reduced head size, and severe defects, such as retarded development. Results are from three independent experiments. dsRed mRNA:
served as a negative control.
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Foxd3 (CWH3, Hfh2, fkd6) is in class V.
foxd3 is expressed in the presumptive neural crest region in
both chick and mouse embryos and plays a role in neural crest
differentiation in multiple systems (Freyaldenhoven et al.,
1997; Hromas et al., 1999; Kos et al., 2001). Overexpression of
foxd3 in a line of myeloid cells prevents them from maturingFig. 5. The effect of inhibiting Foxd3 protein translation on somitogenesis in
zebrafish embryos. Lateral and dorsal views of wild-type (upper panels) and
foxd3-MO1-injected (lower panels) 12- to 14-somite stage embryos. Embryos
that were injected with 10 ng of foxd3-MO1 displayed an abnormal phenotype,
including an abnormal tail bud, a reduced head (A vs. B), and wider somites
with an irregular somite boundary (C vs. D). Scale bars: 100 Am.into granulocytes (Xu et al., 1998). Ectopic expression of foxd3
in the neural tube of chicks changes the fate of cells into neural
crest-like cells and can interfere with subsequent differentiation
(Dottori et al., 2001). In addition to the somatic mesoderm,
zebrafish foxd3 is transcribed in the somitic mesoderm,
paraxial mesoderm, and tail bud (Odenthal and Nu¨sslein-
Volhard, 1998; Fig. 4). Whether foxd3 is involved in
myogenesis is unknown. Previously, we demonstrated that a
cis-element (82/62) of zebrafish myf5 drives somite-
specific expression and represses nonspecific expression during
the early development of zebrafish embryos (Chen et al.,
2003). In this study, we discovered that the winged helix
transcription factor foxd3 interacts specifically with the myf5
82/62 cassette (Fig. 2). The dual-luciferase assay revealed
that the expression of Foxd3 potently transactivated the myf5
promoter (Fig. 3) and that foxd3 plays an important role in
mediating myf5 expression during somitogenesis.
Foxd3 is necessary for maintaining myf5 expression in somites
Many regulatory modules are thought to be responsible for
directing the spatiotemporal expression of myf5. Transplanta-
tion and knockout studies in mice indicate the somites are
induced by factors secreted from a variety of adjacent tissues,
such as Shh (Fan and Tessier-Lavigne, 1994), Wnts (Mu¨nster-
berg et al., 1995; Stern et al., 1995), Pax3 (Maroto et al., 1997;
Tajbakhsh et al., 1997), and BMP (Pourquie´ et al., 1996;
Dietrich et al., 1998). These environmental signals affect the
initiation and continued expression of myf5 in the somites.
Here, we find that Foxd3, another regulatory module, has a
novel function in myf5 expression due to the finding that down-
regulation of foxd3 suppresses myf5 expression in the somites.
Fig. 6. Whole-mount in situ hybridizations showing gene expression in wild-type (A–F) and the foxd3-MO1-injected embryos (G–L) at different somite stages. In
embryos with 8 to 19 somites, myf5 expression in the somites and adaxial cells of foxd3-MO1-injected (10 ng) embryos was much lower than in wild-type embryos.
Weak myf5 signals appeared in somites 0 and 1 (arrowheads) and in presomitic mesoderm. Ectopic expression of myf5 was observed in the tail bud (arrow in H).
By the 20- to 24-somite stage, myf5 expression patterns in foxd3-MO1-injected and wild-type embryos were similar (E, F vs. K, L). Scale bars: 100 Am.
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adaxial cells in the Foxd3 knockdown embryos (Figs. 6C, I).
Addition of myf5 mRNA effectively rescues the expression of
both myogenin and a-actin (Fig. 7) in the somites of foxd3
morphants, indicating that foxd3 modulates myf5 expression
specifically. However, myf5 expression remains unchanged in
the PSM of Foxd3 knockdown embryos. The endogenous
foxd3 is not expressed in the PSM (Odenthal and Nu¨sslein-
Volhard, 1998; Fig. 4). Therefore, we propose that foxd3
functions in newly formed somites but not in the PSM.
The expression of zebrafish myf5 is stage-specific and is
restricted, particularly in the posterior part of each somite
(Chen et al., 2001; Coutelle et al., 2001). Very little is known
about the regulators that are involved in this delicate expression
of myf5. In this report, we demonstrate clearly that Foxd3 is a
trans-acting factor that binds directly at the upstream cis-
elements of zebrafish myf5 gene. Knockdown of Foxd3 level
leads to a reduction of myf5 transcripts in the newly formed
somites but not in the PSM (Fig. 6). Thus, we propose that
Foxd3 functions to maintain the continued expression of myf5
in the somites but does not function to initiate myf5 expression
in the PSM. Moreover, we find that myf5 and foxd3 transcripts
are co-localized in the posterior part of newly formed somites.
Misexpression of foxd3 leads to the ectopic expression of myf5
but not myod (data not show). These results indicate that foxd3may function to restrict myf5 expression in the posterior part of
somites. In addition, myod was expressed normally in the
posterior part of the somites in the foxd3 morphants, suggesting
that the mechanism of restricting expression of myf5 is
independent of myod.
Compared with the expression pattern of myf5, foxd3
transcripts reached a relatively high level at the 9- to 18-
somite stage, then foxd3 was down-regulated rapidly after 24
hpf (Odenthal and Nu¨sslein-Volhard, 1998; data not shown).
Similarly, myf5 transcripts increased substantially until the 16-
to 18-somite stage and then declined gradually to an
undetectable level by 26 hpf (Chen et al., 2001). In this report,
we find that myf5 expression patterns in the wild-type embryos
and in the foxd3 morphants are similar after the 20- to 22-
somite stage, although the expression level of foxd3 in the
somites was still strong at these stages. However, zebrafish
myf5 transcripts in the somites became weaker and weaker after
the 14- to 16-somite stage, and the transcripts were present
only in the PSM close to the tail bud by 24 hpf (Chen et al.,
2001). Taken together, we propose that the foxd3 modulation
on myf5 expression is stage-dependent. Foxd3 is required for
myf5 activation in the somites between the 7- to 18-somite
stage, suggesting different factors and mechanisms are in-
volved in myf5 down-regulation or perturbed Foxd3 functions
in myf5 activation after the 17-somite stage.
Fig. 7. Effect of inhibiting Foxd3 protein synthesis on myf5, myod, myogenin, and a-actin expression in embryos with 10–12 somites. In foxd3-MO1-injected (10
ng) embryos, myf5 expression in the somites, adaxial cells, and presomitic mesoderm was reduced dramatically (A vs. E) but myod expression was unchanged (B vs.
F). In foxd3-MO1-injected embryos, the expression of myogenin (C vs. G) and a-actin (D vs. H) was abolished in the somites, except in adaxial cells. Embryos
injected with 4 ng of myf5-MO exhibited reduced myogenin expression in the somites, a finding similar to the defective phenotype of foxd3 morphants (I vs. G). Co-
injection of 600 ng/Al myf5-capped mRNA rescued expression of myogenin (J) and a-actin (K) in foxd3-MO1-injected embryos. Scale bars: 100 Am.
H.-C. Lee et al. / Developmental Biology 290 (2006) 359–372 367We also found that foxd3 morphants express myf5 ectopi-
cally in the tail bud (Fig. 6H). However, cells located in the tail
bud do not express myf5 or myod. Endogenous foxd3 also was
expressed in the tail bud. There are two explanations for this
finding: first, we propose that foxd3 mediates myf5 expression
in the somites differently than in the tail bud. The function of
foxd3 may be similar to the Wnt signal, which has different
effects on the cranial paraxial mesoderm and on the trunk
(Tzahor et al., 2003). Second, the effect may be due to aconvergence-extension defect during gastrulation. Zebrafish
mutants, such as spadetail, have a severe defect in conver-
gence-extension of the trunk paraxial mesoderm. They lose
trunk somites, resulting in paraxial mesoderm cells accumu-
lating in the tail (Kimmel et al., 1989). These hypotheses merit
further investigation.
In foxd3 morphants, the morphological changes we find by
24 hpf are that somites become wider, with an irregular somite
boundary (Figs. 5C, D). But these embryos are able to twitch as
Table 2
Rescue experiment: myogenin and a-actin expressions in the zebrafish embryos co-injected with myf5 mRNA and foxd3-MO1
Co-injection of 8 ng
foxd3-MO1 and
different concentrations
of myf5 mRNA
myogenin a-actin
Experimental
embryos
No
expressiona
Partial
expressionb
Wild-type
embryos
Experimental
embryos
No
expressiona
Partial
expressionb
Wild-type
embryos
0 pg 67 54 (81%) 5 (7%) 8 (12%) 72 49 (68%) 13 (32%) 10 (14%)
300 pg 235 117 (50%) 43 (18%) 75 (32%) 164 44 (27%) 72 (44%) 48 (29%)
600 pg 186 15 (8%) 95 (51%) 76 (41%) 129 19 (15%) 68 (53%) 42 (32%)
Embryos were co-injected with different concretion of myf5 mRNA and 8 ng foxd3-MO1, then fixed at 16-hpf and examined by whole mount in situ hybridization
for myogenin and a-actin.
a The number of embryos that did not exhibit expression in the somites.
b The number of embryos that exhibited weak expression in the somites.
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morphology of foxd3 morphants remains unchanged during 3
to 5 days post-fertilization. Moreover, only embryos that
received both myf5- and myod-MO lost somites (data not
shown). Nevertheless, embryos that received foxd3-, myf5-, or
myod-MO alone still were able to develop somites normally.
Taken together, these findings may be because myf5 and myod
have complementary functions during somitogenesis. The
function of zebrafish Myf5 is redundant during somitogenesis.
However, whether Myf5 and Myod still play complementary
roles in the muscle system other than somite, such as
craniofacial muscle development, is worthwhile to study.
In the caudal region, paraxial mesoderm is produced by
gastrulation in the primitive streak or tail bud. The foxd3-MO-
injected embryos displayed abnormal heads, defective tails,
and wider somites (Figs. 5). Moreover, myf5 mRNA did not
rescue the morphological defects induced by foxd3-MO1
(Table 1). We speculate this abnormal phenotype may be due
to a convergence-extension defect during gastrulation, but may
be not related during somitogenesis. In zebrafish, Odenthal and
Nu¨sslein-Volhard (1998) demonstrated that there is a strong
expression of foxd3 in the involuting dorsal mesoderm.
Mutation in zebrafish trilobite (tri) or knypek (kny) gene
affects the convergence-extension movements. Somites in the
tri, kny, or kny;tri mutant appear substantially wider in their
mediolateral dimension (Solnica-Krezel et al., 1996; Marlow et
al., 1998; Sepich et al., 2000; Henry et al., 2000). In mouse,
Foxd3/ embryos are dead after implantation at approximate-
ly 6.5 days post coitum, with a loss of epiblast cells, expansion
of proximal extraembryonic tissues, and a distal, mislocalized
anterior organizing center, suggesting that Foxd3 is required
for maintaining embryonic cells of the early mouse embryo
(Hanna et al., 2002). Taken together, it is highly possible that
zebrafish Foxd3 may function during gastrulation. Loss of
Foxd3 function causes abnormal heads, abnormal tails, and
wider somites, evident as the defective phenotype displayed by
foxd3 morphants.
Regulation of myf5 by pax3 is mediated by foxd3
Pax3 belongs to the family of paired-box-containing
transcription factors. It is expressed in developing somites,
the dorsal spinal cord, mesencephalon, and neural crest
derivatives. Heterozygous Splotch mice are characterized bypigmentation defects due to a disorder in neural crest
formation. Furthermore, homozygous embryos exhibit neural
defects, including spina bifida and exencephaly (Tremblay and
Gruss, 1994). All neural crest derivatives caudal to the
boundary of the hindbrain and spinal cord are lost. In addition,
foxd3 is not expressed in the caudal region of Splotch mutants,
where dorsal root ganglia and sympathetic ganglia are missing.
Thus, in dorsal neural tube progenitors, foxd3 is genetically
downstream of pax3 (Dottori et al., 2001). Ectopic expression
of pax3 throughout the neural tube alters the dorsal–ventral
characteristics of the neural tube, represses floor plate
formation, and decreases motor neuron differentiation in
transgenic mice embryos (Tremblay et al., 1996). Forced
expression of pax3 can activate expression of both myod and
myf5 in paraxial mesoderm cultures and in neural tube
explants. In addition, genetic and in vitro analysis determined
that pax3 regulation of mouse myf5 is indirect (Maroto et al.,
1997; Tajbakhsh et al., 1997; Roth et al., 2003).
pax3 plays a distinct role in the development of myogenic
precursors and is thought to function upstream of myod
(Marcelle et al., 1995; Maroto et al., 1997; Tajbakhsh et al.,
1997). The Splotch mutant lacks limb musculature (Franz et
al., 1993; Bober et al., 1994), demonstrating that pax3 is
necessary for the migration of muscle precursor cells (Bober et
al., 1994; Goulding et al., 1994; Marcelle et al., 1995). myod is
not activated in the Splotch/myf5 double null mutant, suggest-
ing that myod acts genetically downstream of pax3 and myf5 in
the establishment of skeletal muscle in the body (Tajbakhsh et
al., 1997). Relaix et al. (2003) showed that pax3 cannot
directly activate the distal myod enhancer, indicating that pax3
activates myod indirectly. Thus, whether Pax3 acts directly on
myod in mammals remains unclear. In zebrafish, the expression
of pax3 is observed first in somites of embryos at the 6- to 8-
somite stage. Transcripts are detected in most of the somites
until the 14- to 16-somite stage; subsequently, expression is
reduced (Seo et al., 1998). In this report, embryos that received
pax3-MOs display severe convergence/extension phenotypes.
This consequence may be because pax3 is detected initially at
the neural plate stage (Seo et al., 1998) and functions during
gastrulation. Both pax3 and foxd3 morphants display defective
convergence/extension phenotypes, and foxd3 expression is
down-regulated greatly in pax3-MO1-injected zebrafish em-
bryos, suggesting that pax3 functions upstream of foxd3.
However, the stripe pattern of myf5 can be rescued by foxd3
Fig. 9. Models of the myf5 regulation network during somitogenesis in mice
and zebrafish. (a) myod functions downstream of pax3 (Tajbakhsh et al., 1997).
(b) pax3 activates myod indirectly (Relaix et al., 2003).
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extension phenotype cannot (Table 1). Actually, the molecular
mechanism about pax3 and foxd3 involved in gastrulation are
still unclear at the present study. Taken together, we speculate
that foxd3 may be one of the downstream target genes of pax3
during gastrulation. Over-expression of foxd3 in pax3 mor-
phants could not rescue all the functions that pax3 plays.
Besides, it is also reasonable to speculate that Pax3 and Foxd3
seems to be acting in independent ways during gastrulation.In pax3 morphants, myf5 expression is restricted to the
PSM, as is the case in foxd3 morphants. In addition, the pax3
(Seo et al., 1998) and foxd3 (Fig. 4) transcripts are not
detectable in the PSM. Over-expression of foxd3 mRNA in
pax3 morphants rescues the stripe patterns of myf5 in the
somites, indicating that these factors are permissive for the
expression of the target genes, but not instructive. Taken
together, these findings suggest that myf5 down-regulation
occurs in pax3 morphants, because foxd3 is not expressed.
Pax3 and Foxd3 function to maintain myf5 expression in the
newly formed somites. Moreover, our analysis of zebrafish
foxd3 and pax3 morphants demonstrated that foxd3 specifically
regulates expression of myf5 but not myod (Figs. 7, 8). These
data suggest that Pax3 may activate the expression of myf5 and
myod through a different regulatory mechanism. Therefore, we
propose a model in which the signaling cascade involved in
muscle development begins with pax3 inducing foxd3 expres-
sion, which then induces myf5 expression (Fig. 9).
Delicate network of myf5 regulation during embryogenesis
The function of cassette 82/62 is to recruit a trans-factor
to drive somite-specific expression. Several studies have found
that a transcription factor interacts with a ubiquitous factor to
drive tissue-specific expression. In neuron-specific expression,
a neuron-restricted transcription factor, MASH1, interacts with
CBF to drive tissue-specific expression (Mandolesi et al.,
2002). Cardiac-specific expression is directed by the interac-
tion of a heart-specific factor, myocardin, with a ubiquitous
serum response factor bound to a CArG box (Wang et al.,
2001). We found that the trans-factor Foxd3 binds to the 82/
62 cis-element and has a novel function during myogenesis.
This function is totally distinct from previously knownFig. 8. The effect of inhibiting Pax3 protein synthesis on the expression of
foxd3, myf5, and myod in the zebrafish embryos at 5 to 8 somites. Probes were
used to detect myf5 (A, B, C), foxd3 (D, E), and myod (F, G, H) in the wild-
type embryos (A, D, F), the pax3-MO1-injected (6 ng) embryos (B, E, G), and
the embryos co-injected with 6 ng of pax3-MO1 and 25 pg of foxd3 mRNA
(C, H). (B) In pax3-MO1-injected embryos, myf5 expression was restricted in
the presomitic mesoderm (PSM) and weak in somites 0 and 1 and in the
adaxial cells on the sides of somites 0 and 1. (E) The shape of the neural
plate became abnormal in the pax3-MO1 morphants, and foxd3 expression
was weak in their neural fold and tail bud. (G) Meanwhile, myod expression
was down-regulated in the somites, but it was expressed in adaxial cells. In the
rescue experiment, co-injection of foxd3 mRNA and pax3-MO1 restored myf5
expression in the somites (C), whereas the myod expression was not rescued
(H). Scale bars: 100 Am.
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esize that Foxd3 interacts with different cofactors in the
somites and neural crest cells. In addition, we think that the
effect of Foxd3 in the tail bud is different from its effect in the
somites. This difference occurs because different cofactors bind
to cassette 82/62. As a result, Foxd3 plays a unique role in
regulating myf5 expression. These hypotheses merit further
investigation.
A trans-acting factor can function as both an activator and a
repressor, depending on its binding sequence and/or its
interaction with a specific cofactor. Transcription factors YY1
(Shrivastava and Calame, 1994; Shi et al., 1997) and NF-Y
(Peng and Jahroudi, 2002) function in this way. Moreover, the
ectopic expression of Foxd3 in the chick neural tube induces
expression of migratory neural crest markers but suppresses
interneuron differentiation (Dottori et al., 2001). Over-expres-
sion of Foxd3 prevents the migration of neural crest cells along
the dorsolateral migratory pathway, suggesting that Foxd3
suppresses melanogenesis (Kos et al., 2001). We found that
Foxd3 has opposite effects in the somites and tail bud and can
function as both an activator and a repressor. Recently, we
reported that a cis-acting element in the downstream region
(+502/+835) of zebrafish myf5 intron 1 represses myf5
expression (Lin et al., 2004). On the basis of these results,
we hypothesize that the zebrafish myf5 82/62 cassette, the
intron 1 +502/+835 element, Foxd3 and other unknown
factors, and even a cis-element located in the distal upstream
region form a huge complex that orchestrates the spatiotem-
poral expression of myf5 during somitogenesis.
In summary, we characterized signals that modulate
somitogenesis. Our results reveal that the winged helix
transcription factor Foxd3 plays an important role in maintain-
ing myf5 expression in the newly formed somites and the
adaxial cells. We propose a model of gene regulation in which
pax3 induces foxd3 expression, which then induces the
expression of myf5. However, because inhibition of foxd3
translation does not completely abolish myf5 expression in the
PSM, we speculate that factors other than Foxd3 are involved
in regulating myf5 expression in the PSM.
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